title: Effect of complete remission on survival in patients with acute myelogenous leukemia receiving first salvage therapy.
authors.forename: N
authors.initials: N
authors.lastname: Vey
authors.forename: M
authors.initials: M
authors.lastname: Keating
authors.forename: F
authors.initials: F
authors.lastname: Giles
authors.forename: J
authors.initials: J
authors.lastname: Cortes
authors.forename: M
authors.initials: M
authors.lastname: Beran
authors.forename: E
authors.initials: E
authors.lastname: Estey
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D018572:Disease-Free Survival; D005500:Follow-Up Studies; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D012189:Retrospective Studies; D016879:Salvage Therapy; D016019:Survival Analysis; D013997:Time Factors
chemical_list: D003561:Cytarabine